In addition, expression of EXT1, but not SLC35B2, was positively correlated with the YAP1/TAZ score in the TCGA cohort of BRAF mutant melanoma (Fig. 5g), suggesting that EXT1 is a YAP1/TAZ target. Here, SLC35B2 is linked to melanoma.